The role of neoadjuvant chemotherapy in NSCLC

Chest

Volumn 109, Issue 5 SUPPL., 1996, Pages 93S-95S

  Tonato, Maurizio ^a  

^a Policlinico Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MITOMYCIN C; PLATINUM; VINBLASTINE;

CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; DOSE RESPONSE; HUMAN; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; HUMANS; LUNG NEOPLASMS; QUALITY OF LIFE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0029981491     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.5_Supplement.93S     Document Type: Article

References (13)

1. Klastersky J, Burkers R, Choi N, et al. Induction therapy for NSCLC: a consensus report. Lung Cancer 1991; 7:15-7
2. Mountain CF, Lukeman JM, Hammar SP, et al. The relationship of disease extent and cell type to survival in a clinical trial population. J Surg Oncol 1987; 35:147-56
3. Shepherd FA. Induction chemotherapy for locally advanced non-small cell lung cancer. Ann Thorac Surg 1993; 55:1585-92
4. Ginsberg RJ. Multimodality treatment for stage IIIA (N2) lung cancer: an overview. Chest 1993; 103(suppl):356-59
5. Kris MG. Induction chemotherapy in the treatment of patients with stage IIIA (N2) non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center experience. In: Chemotherapy of non-small cell lung cancer: five years later. Proceedings of the Perugia International Cancer Conference IV, Perugia, Italy, 1994
6. Burkes R, Ginsberg R, Shepherd F, et al. Induction chemotherapy with mitomycin C, vindesine and cisplatin for stage III unresectable non-small cell lung cancer: results of the Toronto phase II trial. J Clin Oncol 1992; 10:580-86
7. Darwish S, Minotti V, Crinò L, et al. Neoadjuvant cisplatin and etoposide for stage IIIA (clinical N2) non-small cell lung cancer. Am J Clin Oncol 1994; 17:64-7
8. Elias AD, Skarin AT, Gonin R, et al. Neoadjuvant treatment of stage IIIA non-small cell lung cancer. Am J Clin Oncol 1994; 17:26-36
9. Albain K, Rusch V, Crowley J, et al. Concurrent cisplatin/etoposide and chest radiation (CRT) followed by surgery for stages 3A (N2) and 3B non-small cell lung cancer: completed analysis of SWOG-8805 [abstract]. Proc Am Soc Clin Oncol 1994; 13:120
10. Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994; 330:153-58
11. Roth JAB, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 1994; 86:673-80
12. Johnson DH, Piantadosi S. Chemotherapy for resectable stage III non-small cell lung cancer - can that dog hunt? J Natl Cancer Inst 1994; 86:650-51
13. Strauss GM, Langer MP, Elias AD, et al. Multimodality treatment of stage IIIA non-small cell lung carcinoma: a critical review of the literature and strategies for future research. J Clin Oncol 1992; 10:829-38